Search

everythinglearnresearchcommunity

for

Search:↓

Electron Beam Tomography (EBT) is a useful additional test to stress testing for detecting heart disease.

The drug TGU was ineffective against small cell lung cancer and caused significant bone marrow suppression.

Tapinarof cream at 1% concentration is effective and better tolerated for treating atopic dermatitis than the 2% concentration.

Tofacitinib may help treat nail dystrophy, especially when other treatments fail.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

SQSTM1 gene issues may increase the risk of alopecia areata.

Tisseel shows promise for bone graft stabilization but needs more clinical trials to confirm its effectiveness.

Microneedle arrays deliver botulinum toxin effectively for sweat suppression, similar to injections.

Semecarpus anacardium leaf extracts may offer safe, effective cancer treatment alternatives.

Bexxar is highly effective as a first treatment for non-Hodgkin's lymphoma, with most patients alive and many in remission after eight years.

Tofacitinib was more effective than methotrexate for treating alopecia areata.

Tofacitinib is an effective and safe treatment for alopecia areata.

MNC-QQ cell therapy improved hair growth and quality of life in men with androgenic alopecia without adverse effects.

Tofacitinib shows promise for treating severe alopecia areata with good safety and effectiveness.

TAF4 is important for skin cell growth and helps prevent skin cancer in mice.

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

A patient with alopecia had hair regrowth with tofacitinib but developed a skin reaction, choosing to continue the treatment despite the side effect.

Upadacitinib may effectively treat twenty-nail dystrophy without causing pain.

A new classification for trichothiodystrophy helps identify genetic causes and potential treatments.

Ritlecitinib reduces alopecia areata symptoms by blocking JAK3/TEC signaling and T-cell activity.

The hydrogel quickly stops bleeding and helps heal infected wounds.

2-Hydroxy-1,4-naphthoquinone is a strong 5α-reductase inhibitor.

Dual-targeted therapy is effective and safe for difficult-to-treat inflammatory bowel disease.

A new non-invasive laser system improves chronic disease management and metabolic health.

Tideglusib with a bacterial cellulose hydrogel improves wound healing in rats.

CTP-543 effectively promotes hair regrowth in adults with moderate to severe alopecia areata.

Self-amplifying RNA could be a better option for protein replacement therapy with lower doses and lasting effects, but delivering it into cells is still challenging.

Peptide-based PROTACs show promise in targeting hard-to-treat proteins, especially for cancer therapy.

A new test helps find drugs to treat head and neck cancer by targeting c-Rel.